… Aspects of this heterogeneity have been implicated in tumour evolution, metastasis and
acquired therapeutic resistance. Although clinical progress in SCLC treatment has been …

… derivatives to the anti-cancer repertoire following the entry of … administration, and some
side effects such as peripheral … side effects and improved drug delivery capacity for cancer …

… -Gly had significant cytotoxic effects and no apparent side effects. 18β-Gly induced
mitochondria-dependent apoptosis of A549 lung cancer cells. In addition, after treatment with 18β-Gly…

… in tumor cells and elevate the sensitivity of tumor cells to chemotherapy and radiotherapy for
tongue and breast cancer [… fewer side effects, make it a widely acceptable drug among lung …

… The toxicity and side effects of anti-cancer drugs are constantly raised issues and hinder
the rapid development of new drugs. PPT derivatives of 1 mg/kg significantly inhibited …

… protects against cell death and increases the survival of cancer cells, we examined the
effects of … The expression levels of 14-3-3 proteins in A549 cells after treatment with various …

… ≥ 50% or tumor infiltrating immune cells ≥ 10%, compared … with PD-L1 tumor cells ≥ 5%
or tumor infiltrating immune cells ≥ 5% [… Grade 3 or 4 treatment-related adverse effects were …

… The negative regulation of mTOR by AMPK is what links cellular energy and mTORC1
regulation 21 . ULK, a serine/threonine kinase, may function as a bridge between energy sensors (…

… , with fewer side effects compared with classic chemotherapeutic agents. Multiple treatment
options are now available for patients with advanced non–small cell lung cancer, ranging …

… this article, the side effects of immune … side effects due to excessive autoimmune reactions,
which are relatively infrequent and if present, are usually mild, allowing continued treatment …